• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An ionic liquid promoted microwave-hydrothermal route towards highly photoluminescent carbon dots for sensitive and selective detection of iron(iii)?
  Ruili Liu,Mengping Gao,Jing Zhang,Zhilian Li,Jinyang Chen,Ping Liu,Dongqing Wu RSC Adv., 2015,5, 24205-24209
• 3. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 4. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

Recent Advances in the Study of 1-(aminooxy)methyl-2-chloro-4-fluorobenzene hydrochloride (CAS: 317821-68-4)

1-(aminooxy)methyl-2-chloro-4-fluorobenzene hydrochloride (CAS: 317821-68-4) is a specialized chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique aminooxy and halogenated benzene structure, has been explored for its potential applications in drug development, particularly in the design of enzyme inhibitors and targeted therapeutics. Recent studies have focused on its synthesis, reactivity, and biological activity, providing new insights into its utility in medicinal chemistry.

The synthesis of 1-(aminooxy)methyl-2-chloro-4-fluorobenzene hydrochloride has been optimized in recent years to improve yield and purity. A 2023 study published in the Journal of Medicinal Chemistry detailed a novel synthetic route that employs a one-pot reaction strategy, significantly reducing the number of steps required and minimizing byproduct formation. This advancement has facilitated larger-scale production, enabling more extensive pharmacological evaluations. The study also highlighted the compound's stability under physiological conditions, a critical factor for its potential use in vivo.

In terms of biological activity, 1-(aminooxy)methyl-2-chloro-4-fluorobenzene hydrochloride has shown promise as a reversible inhibitor of certain enzymes involved in inflammatory pathways. Research published in Bioorganic & Medicinal Chemistry Letters (2024) demonstrated its efficacy in selectively targeting myeloperoxidase (MPO), an enzyme implicated in chronic inflammatory diseases. The compound's ability to form stable adducts with MPO's active site was confirmed through X-ray crystallography, providing a structural basis for its inhibitory mechanism. These findings suggest its potential as a lead compound for developing anti-inflammatory drugs.

Further investigations have explored the compound's pharmacokinetic properties. A preclinical study conducted in 2024 evaluated its absorption, distribution, metabolism, and excretion (ADME) profiles in rodent models. The results indicated favorable oral bioavailability and a half-life suitable for once-daily dosing. However, the study also noted the need for further optimization to reduce renal clearance, which could enhance its therapeutic efficacy. These findings underscore the compound's potential while highlighting areas for future research.

Beyond its direct pharmacological applications, 1-(aminooxy)methyl-2-chloro-4-fluorobenzene hydrochloride has been utilized as a versatile building block in chemical biology. Its aminooxy group enables efficient conjugation with carbonyl-containing molecules, making it valuable for bioconjugation strategies. Recent work in ACS Chemical Biology (2023) showcased its use in generating antibody-drug conjugates (ADCs) with improved stability and targeting specificity. This application opens new avenues for precision medicine, particularly in oncology.

In conclusion, 1-(aminooxy)methyl-2-chloro-4-fluorobenzene hydrochloride (CAS: 317821-68-4) represents a multifaceted compound with significant potential in drug discovery and chemical biology. Recent advancements in its synthesis, mechanistic understanding, and therapeutic applications have positioned it as a promising candidate for further development. Future research should focus on optimizing its pharmacokinetic properties and expanding its utility in targeted therapies. The compound's unique chemical features and demonstrated biological activity make it a valuable asset in the ongoing quest for novel pharmaceuticals.

• 288154-93-8(2-Chloro-4,5-difluorobenzyl Alcohol)
• 261762-83-8(2-Chloro-6-fluoro-3-methylbenzyl alcohol)
• 261762-84-9(6-Chloro-2-fluoro-3-methylbenzyl alcohol)
• 55418-30-9(O-(2-chlorophenyl)methylhydroxylamine)
• 5555-48-6(O-(2-Chlorobenzyl)hydroxylamine hydrochloride)
• 56456-50-9(2-Chloro-6-fluorobenzyl alcohol)
• 208186-84-9(2-Chloro-4-fluorobenzyl alcohol)
• 1803718-67-3(2,3-Dichloro-5-fluorobenzyl alcohol)
• 261762-59-8(2-Chloro-5-fluorobenzyl alcohol)
• 93081-15-3(2-(aminooxy)methyl-1-chloro-3-fluorobenzene hydrochloride)